drugset / Trial / NCT03120520
An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a study of efficacy and safety of Plecanatide in pediatric subjects aged 12 to \< 18 years diagnosed with Chronic Idiopathic Constipation.
Timeline
- Start
- 2017-01
- Primary completion
- 2018-09-07
- Completion
- 2018-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plecanatide | Peptide | 0.5 mg | Oral |
| Subject | Plecanatide | Peptide | 1 mg | Oral |
| Subject | Plecanatide | Peptide | 1.5 mg | Oral |